{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:31:11Z","timestamp":1793946671514,"version":"4.8.0"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013314","name":"Higher Education Discipline Innovation Project","doi-asserted-by":"publisher","award":["B18035"],"award-info":[{"award-number":["B18035"]}],"id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["25NSFSC2417"],"award-info":[{"award-number":["25NSFSC2417"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jconrel.2026.114847","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:14:18Z","timestamp":1774545258000},"page":"114847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Renal-targeted drug delivery: overcoming barriers and charting the course"],"prefix":"10.1016","volume":"394","author":[{"given":"Chen","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114847_bb0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41581-025-01045-x","article-title":"Toward an understanding of the intrinsic kidney response to acute injury","volume":"22","author":"Chen","year":"2026","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0010","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"International society of, chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41581-024-00829-x","volume":"20","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pharmthera.2016.03.015","article-title":"Renoprotective approaches and strategies in acute kidney injury","volume":"163","author":"Yang","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2026.114847_bb0025","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1080\/0886022X.2019.1662440","article-title":"Predictive role of estimated glomerular filtration rate prior to surgery in postsurgical acute kidney injury among very elderly patients: a retrospective cohort study","volume":"41","author":"Wu","year":"2019","journal-title":"Ren. Fail."},{"key":"10.1016\/j.jconrel.2026.114847_bb0030","series-title":"National and Provincial Insights From the Global Burden of Diseases study 2023","article-title":"Chronic kidney disease burden from 1990 to 2023 in China","author":"He","year":"2025"},{"key":"10.1016\/j.jconrel.2026.114847_bb0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000520698","article-title":"Role of Mitochondrial Therapy for Ischemic-Reperfusion Injury and Acute Kidney Injury","volume":"146","author":"Pabla","year":"2022","journal-title":"Nephron"},{"key":"10.1016\/j.jconrel.2026.114847_bb0040","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41581-020-00369-0","article-title":"Mitochondrial quality control in kidney injury and repair","volume":"17","author":"Tang","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0045","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1097\/01.ASN.0000079785.13922.F6","article-title":"Recent advances in the pathophysiology of ischemic acute renal failure","volume":"14","author":"Bonventre","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0050","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1681\/ASN.2015010006","article-title":"Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression","volume":"26","author":"Venkatachalam","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105910","article-title":"Epigenetic regulation in fibrosis progress","volume":"173","author":"Xue","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2026.114847_bb0060","series-title":"Renal Vascular Structure and Rarefaction","first-page":"817","author":"Chade","year":"2013"},{"key":"10.1016\/j.jconrel.2026.114847_bb0065","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1046\/j.1523-1755.2000.00031.x","article-title":"Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists","volume":"57","author":"Taal","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2026.114847_bb0070","series-title":"Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled Trials","first-page":"193","volume":"39","author":"Garcia Sanchez","year":"2022"},{"key":"10.1016\/j.jconrel.2026.114847_bb0075","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejmech.2019.01.043","article-title":"Pharmacological urate-lowering approaches in chronic kidney disease","volume":"166","author":"Li","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.114847_bb0080","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41581-025-00931-8","article-title":"Risk-directed management of chronic kidney disease","volume":"21","author":"Blum","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41574-025-01171-3","article-title":"Mechanisms of diabetic kidney disease and established and emerging treatments","volume":"22","author":"Martinez Leon","year":"2026","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2025","key":"10.1016\/j.jconrel.2026.114847_bb0090","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.kint.2024.07.010","article-title":"clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary","volume":"107","author":"Torres","year":"2025","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2026.114847_bb0095","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.kint.2020.09.032","article-title":"Three-dimensional architecture of nephrons in the normal and cystic kidney","volume":"99","author":"Blanc","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2026.114847_bb0100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1083\/jcb.201410017","article-title":"Review series: The cell biology of renal filtration","volume":"209","author":"Scott","year":"2015","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0105","doi-asserted-by":"crossref","first-page":"F831","DOI":"10.1152\/ajprenal.00313.2016","article-title":"Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?","volume":"311","author":"Marshall","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0110","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/aps.2016.44","article-title":"Renal-targeting triptolide-glucosamine conjugate exhibits lower toxicity and superior efficacy in attenuation of ischemia\/reperfusion renal injury in rats","volume":"37","author":"Fu","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2026.114847_bb0115","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3109\/1061186X.2013.856011","article-title":"Conjugating glucosamine to triptolide to enhance its protective effect against renal ischemia-reperfusion injury and reduce its toxicity","volume":"22","author":"Zhou","year":"2014","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2026.114847_bb0120","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.fitote.2015.04.008","article-title":"A renal-targeted triptolide aminoglycoside (TPAG) conjugate for lowering systemic toxicities of triptolide","volume":"103","author":"Qi","year":"2015","journal-title":"Fitoterapia"},{"key":"10.1016\/j.jconrel.2026.114847_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116365","article-title":"Tripterygium wilfordii protects against an animal model of autoimmune hepatitis","volume":"309","author":"Zhang","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155054","article-title":"Celastrol as an intestinal FXR inhibitor triggers tripolide-induced intestinal bleeding: Underlying mechanism of gastrointestinal injury induced by Tripterygium wilfordii","volume":"121","author":"Dai","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jconrel.2026.114847_bb0135","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1021\/acsomega.7b01890","article-title":"Novel Low-Toxic Derivative of Celastrol Maintains Protective Effect against Acute Renal Injury","volume":"3","author":"Hu","year":"2018","journal-title":"ACS Omega"},{"issue":"8","key":"10.1016\/j.jconrel.2026.114847_bb0140","first-page":"627","article-title":"Kidney-targeting characteristics of N-acetyl-L-glutamic prednisolone prodrug","volume":"38","author":"Min Su","year":"2003","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.jconrel.2026.114847_bb0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cclet.2011.07.023","article-title":"Prednisolone succinate\u2013glucosamine conjugate: Synthesis, characterization and in vitro cellular uptake by kidney cell lines","volume":"23","author":"Lin","year":"2012","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2026.114847_bb0150","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.cclet.2012.03.021","article-title":"Synthesis and in vivo distribution of 2-deoxy-2-aminodiglucose\u2013prednisolone conjugate (DPC)","volume":"23","author":"Lin","year":"2012","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2026.114847_bb0155","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ardp.201200232","article-title":"Prednisolone-glucose derivative conjugate: synthesis, biodistribution and pharmacodynamics evaluation","volume":"345","author":"Liu","year":"2012","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.jconrel.2026.114847_bb0160","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jconrel.2013.02.001","article-title":"Targeted drug delivery to renal proximal tubule epithelial cells mediated by 2-glucosamine","volume":"167","author":"Lin","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114847_bb0165","doi-asserted-by":"crossref","first-page":"50828","DOI":"10.1039\/C4RA11160E","article-title":"Renal-specific delivery of prednisolone-folate conjugates for renal ischemia\/reperfusion injury","volume":"4","author":"Zhang","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2026.114847_bb0170","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijpharm.2013.07.064","article-title":"Effects of mycophenolic acid-glucosamine conjugates on the base of kidney targeted drug delivery","volume":"456","author":"Wang","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114847_bb0175","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1021\/mp500282g","article-title":"Mechanistic Studies of a Novel Mycophenolic Acid\u2013Glucosamine Conjugate That Attenuates Renal Ischemia\/Reperfusion Injury in Rat","volume":"11","author":"Wang","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.114847_bb0180","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1039\/C8BM00813B","article-title":"An E-selectin targeting and MMP-2-responsive dextran-curcumin polymeric prodrug for targeted therapy of acute kidney injury","volume":"6","author":"Hu","year":"2018","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.114847_bb0185","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1021\/bc300020f","article-title":"Peptide-drug conjugate linked via a disulfide bond for kidney targeted drug delivery","volume":"23","author":"Geng","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2026.114847_bb0190","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3390\/gels9020115","article-title":"Advanced Drug Delivery Systems for Renal Disorders","volume":"9","author":"Alallam","year":"2023","journal-title":"Gels"},{"key":"10.1016\/j.jconrel.2026.114847_bb0195","doi-asserted-by":"crossref","first-page":"F680","DOI":"10.1152\/ajprenal.00289.2015","article-title":"Human anti-alpha3(IV)NC1 antibody drug conjugates target glomeruli to resolve nephritis","volume":"309","author":"Kvirkvelia","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0200","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.ajt.2023.03.022","article-title":"TNX-1500, a crystallizable fragment-modified anti-CD154 antibody, prolongs nonhuman primate renal allograft survival","volume":"23","author":"Lassiter","year":"2023","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jconrel.2026.114847_bb0205","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.biomaterials.2008.11.035","article-title":"The targeting of 14-succinate triptolide-lysozyme conjugate to proximal renal tubular epithelial cells","volume":"30","author":"Zhang","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114847_bb0210","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1023\/A:1018946219057","article-title":"Low molecular weight proteins as carriers for renal drug targeting: naproxen coupled to lysozyme via the spacer L-lactic acid","volume":"10","author":"Franssen","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2026.114847_bb0215","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12882-020-01833-6","article-title":"Kidney-targeted baicalin-lysozyme conjugate ameliorates renal fibrosis in rats with diabetic nephropathy induced by streptozotocin","volume":"21","author":"Zheng","year":"2020","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0220","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.carbpol.2011.10.060","article-title":"Chitosan oligomers as drug carriers for renal delivery of zidovudine","volume":"87","author":"Liang","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2026.114847_bb0225","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/10611860701289875","article-title":"Randomly 50% N-acetylated low molecular weight chitosan as a novel renal targeting carrier","volume":"15","author":"Yuan","year":"2007","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2026.114847_bb0230","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1021\/mp800078a","article-title":"Specific renal uptake of randomly 50% N-acetylated low molecular weight chitosan","volume":"6","author":"Yuan","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.114847_bb0235","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3109\/1061186X.2010.521158","article-title":"Enhanced accumulation of low-molecular-weight chitosan in kidneys: a study on the influence of N-acetylation of chitosan on the renal targeting","volume":"19","author":"Yuan","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2026.114847_bb0240","article-title":"Megalin-targeted acetylcysteine polymeric prodrug ameliorates ischemia-reperfusion-induced acute kidney injury","volume":"10","author":"Huang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jconrel.2026.114847_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.abb7422","article-title":"ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule","volume":"6","author":"Liu","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.114847_bb0250","article-title":"Chitosan in biomedicine: A comprehensive review of recent developments","volume":"8","author":"Yadav","year":"2024","journal-title":"Carbohydr. Polym. Technol. Appl."},{"key":"10.1016\/j.jconrel.2026.114847_bb0255","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3390\/pharmaceutics15041313","article-title":"Chitosan: A Potential Biopolymer in Drug Delivery and Biomedical Applications","volume":"15","author":"Desai","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114847_bb0260","doi-asserted-by":"crossref","first-page":"49913","DOI":"10.1021\/acsami.4c09665","article-title":"Renal-Targeted Drug Delivery by Chitosan Oligosaccharide Micelles with HSA-Enriched Protein Corona for the Treatment of Ischemia\/Reperfusion-Induced Acute Kidney Injury","volume":"16","author":"Nan","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.114847_bb0265","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/jpet.121.000667","article-title":"Kidney-Targeted Delivery of Prolyl Hydroxylase Domain Protein 2 Small Interfering RNA with Nanoparticles Alleviated Renal Ischemia\/Reperfusion Injury","volume":"378","author":"Xie","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2026.114847_bb0270","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mabi.201100277","article-title":"Dendrimer-based macromolecular conjugate for the kidney-directed delivery of a multitargeted sunitinib analogue","volume":"12","author":"Dolman","year":"2012","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2026.114847_bb0275","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1073\/pnas.1103573108","article-title":"Targeting kidney mesangium by nanoparticles of defined size","volume":"108","author":"Choi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.114847_bb0280","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1021\/acs.molpharmaceut.0c01182","article-title":"Targeting Interstitial Myofibroblast-Expressed Integrin alphavbeta3 Alleviates Renal Fibrosis","volume":"18","author":"Zhou","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.114847_bb0285","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.addr.2017.12.019","article-title":"Targeting renal fibrosis: Mechanisms and drug delivery systems","volume":"129","author":"Nastase","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114847_bb0290","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41581-024-00819-z","article-title":"Physiological principles underlying the kidney targeting of renal nanomedicines","volume":"20","author":"Huang","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0295","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41578-023-00537-1","article-title":"Understanding ligand-protected noble metal nanoclusters at work","volume":"8","author":"Matus","year":"2023","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2026.114847_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(00)00339-4","article-title":"Biodegradable polymeric nanoparticles as drug delivery devices","volume":"70","author":"Soppimath","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114847_bb0305","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.apsb.2013.12.005","article-title":"Kidney-targeted drug delivery systems","volume":"4","author":"Zhou","year":"2014","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.114847_bb0310","doi-asserted-by":"crossref","first-page":"35447","DOI":"10.1021\/acsami.4c04345","article-title":"Glomerulus-Targeted ROS-Responsive Polymeric Nanoparticles for Effective Membranous Nephropathy Therapy","volume":"16","author":"Guo","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.114847_bb0315","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/nat.2014.0505","article-title":"siRNA delivery to the glomerular mesangium using polycationic cyclodextrin nanoparticles containing siRNA","volume":"25","author":"Zuckerman","year":"2015","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.jconrel.2026.114847_bb0320","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1073\/pnas.1200718109","article-title":"Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane","volume":"109","author":"Zuckerman","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.114847_bb0325","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41467-017-00834-8","article-title":"Targeted delivery of celastrol to mesangial cells is effective against mesangioproliferative glomerulonephritis","volume":"8","author":"Guo","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114847_bb0330","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41401-018-0052-4","article-title":"Design and evaluation of glomerulus mesangium-targeted PEG-PLGA nanoparticles loaded with dexamethasone acetate","volume":"40","author":"Li","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2026.114847_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103205","article-title":"Anti-DNA antibody-targeted D-peptide nanoparticles ameliorate lupus nephritis in MRL\/lpr mice","volume":"145","author":"Wang","year":"2024","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jconrel.2026.114847_bb0340","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jconrel.2020.01.024","article-title":"Co-delivery of p38alpha MAPK and p65 siRNA by novel liposomal glomerulus-targeting nano carriers for effective immunoglobulin a nephropathy treatment","volume":"320","author":"Wang","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114847_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138870","article-title":"Targeting Rapamycin to Podocytes Using a Vascular Cell Adhesion Molecule-1 (VCAM-1)-Harnessed SAINT-Based Lipid Carrier System","volume":"10","author":"Visweswaran","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.114847_bb0350","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.2147\/IJN.S141095","article-title":"Renal-targeted delivery of triptolide by entrapment in pegylated TRX-20-modified liposomes","volume":"12","author":"Yuan","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.114847_bb0355","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s11095-006-9213-0","article-title":"Advances in targeting drug delivery to glomerular mesangial cells by long circulating cationic liposomes for the treatment of glomerulonephritis","volume":"24","author":"Morimoto","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2026.114847_bb0360","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1023\/A:1018993000633","article-title":"Uptake of nanoparticles by rat glomerular mesangial cells in vivo and in vitro","volume":"11","author":"Manil","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2026.114847_bb0365","first-page":"381","article-title":"Passively-targeted mitochondrial tungsten-based nanodots for efficient acute kidney injury treatment","volume":"21","author":"Huang","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.114847_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113993","article-title":"Iridium cluster\/hafnium-porphyrin framework heterojunctions for biocatalytic ROS-scavenging and acute kidney injury alleviation","volume":"385","author":"Luo","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114847_bb0375","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41581-024-00914-1","article-title":"Protein handling in kidney tubules","volume":"21","author":"Hall","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0380","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/s41467-025-56223-z","article-title":"High-density lipoprotein nanoparticles spontaneously target to damaged renal tubules and alleviate renal fibrosis by remodeling the fibrotic niches","volume":"16","author":"He","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114847_bb0385","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.kint.2024.06.021","article-title":"Nanotherapeutic kidney cell-specific targeting to ameliorate acute kidney injury","volume":"106","author":"Funahashi","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2026.114847_bb0390","doi-asserted-by":"crossref","first-page":"6607","DOI":"10.1016\/j.apsb.2025.09.017","article-title":"Targeting renal tubular epithelial cells via a dual functionalized oligosaccharide self-assembly in the management of acute and chronic kidney diseases","volume":"15","author":"Xu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.114847_bb0395","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jconrel.2022.07.013","article-title":"Targeted delivery via albumin corona nanocomplex to renal tubules to alleviate acute kidney injury","volume":"349","author":"Qin","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114847_bb0400","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1021\/acs.molpharmaceut.2c00401","article-title":"An Albumin-Enriched Nanocomplex Achieves Systemic Delivery of Clopidogrel Bisulfate to Ameliorate Renal Ischemia Reperfusion Injury in Rats","volume":"19","author":"Wu","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.114847_bb0405","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1021\/acs.molpharmaceut.3c00021","article-title":"Effect of Albumin Corona Conformation on In Vitro and In Vivo Profiles of Intravenously Administered Nanoparticles","volume":"20","author":"Wu","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.114847_bb0410","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41580-020-0251-y","article-title":"RNA delivery by extracellular vesicles in mammalian cells and its applications","volume":"21","author":"O'Brien","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0415","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz0748","article-title":"Extracellular vesicle-encapsulated IL-10 as novel nanotherapeutics against ischemic AKI","volume":"6","author":"Tang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.114847_bb0420","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adt3943","article-title":"A rationally designed injury kidney targeting peptide library and its application in rescuing acute kidney injury","volume":"11","author":"Xiao","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.114847_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101631","article-title":"Ruxolitinib-loaded black phosphorus nanosheets actively target proximal tubule cells to ameliorate nephrotic syndrome by reducing inflammation and oxidative stress","volume":"47","author":"Li","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.114847_bb0430","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202500595","article-title":"A Nanoplatform Targeting Cascade Pathways for Enhanced Triptolide Delivery in Acute Kidney Injury Therapy","volume":"14","author":"Guo","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.114847_bb0435","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1021\/nl504610d","article-title":"Mesoscale nanoparticles selectively target the renal proximal tubule epithelium","volume":"15","author":"Williams","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.114847_bb0440","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.apsb.2020.10.016","article-title":"An injectable micelle-hydrogel hybrid for localized and prolonged drug delivery in the management of renal fibrosis","volume":"11","author":"Qin","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.114847_bb0445","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfae069.1348","article-title":"#1110 The AHR antagonist CH223191 alleviates kidney injury and renal fibrosis in adenine-induced chronic kidney disease","volume":"39","author":"Li","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jconrel.2026.114847_bb0450","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2022.04.004","article-title":"Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosis","volume":"346","author":"Cheng","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114847_bb0455","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jconrel.2020.01.017","article-title":"Targeted delivery of celastrol to renal interstitial myofibroblasts using fibronectin-binding liposomes attenuates renal fibrosis and reduces systemic toxicity","volume":"320","author":"Li","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114847_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111470","article-title":"Blocking 5-LO pathway alleviates renal fibrosis by inhibiting the epithelial-mesenchymal transition","volume":"138","author":"Zhou","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2026.114847_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120902","article-title":"Extended-release of therapeutic microRNA via a host-guest supramolecular hydrogel to locally alleviate renal interstitial fibrosis","volume":"275","author":"Xu","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114847_bb0470","article-title":"Picoeukaryote-based biohybrid microrobots for active delivery in the kidney","volume":"11","author":"Li","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.114847_bb0475","doi-asserted-by":"crossref","first-page":"e1378","DOI":"10.1016\/S2214-109X(25)00198-6","article-title":"Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023","volume":"13","year":"2025","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.jconrel.2026.114847_bb0480","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrneph.2011.149","article-title":"Cellular and molecular mechanisms of renal fibrosis","volume":"7","author":"Liu","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0485","article-title":"Type IV Collagen-Targeting Nanoparticles for Efficient Delivery to the Renal Interstitium in Fibrotic Kidneys","volume":"22","author":"Nakamura","year":"2025","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.114847_bb0490","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adu3730","article-title":"A lipid atlas of the human kidney","volume":"11","author":"Farrow","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.114847_bb0495","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1681\/ASN.0000000608","article-title":"Nanotherapeutics in Kidney Disease: Innovations, Challenges, and Future Directions","volume":"36","author":"Roointan","year":"2025","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0500","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/cr.2015.9","article-title":"Cationic nanocarriers induce cell necrosis through impairment of Na(+)\/K(+)-ATPase and cause subsequent inflammatory response","volume":"25","author":"Wei","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.jconrel.2026.114847_bb0505","first-page":"036","article-title":"Recent Advances on Renal Toxicity of Engineered Nanoparticles-A Review, Journal of Toxicology and Risk","volume":"7","author":"Suresh Vs","year":"2021","journal-title":"Assessment"},{"key":"10.1016\/j.jconrel.2026.114847_bb0510","doi-asserted-by":"crossref","first-page":"19810","DOI":"10.1021\/acsnano.3c04037","article-title":"Meta-Analysis of Nanoparticle Distribution in Tumors and Major Organs in Tumor-Bearing Mice","volume":"17","author":"Chen","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114847_bb0515","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/17435390.2020.1771785","article-title":"Comparative study of nanoparticle uptake and impact in murine lung, liver and kidney tissue slices","volume":"14","author":"Bartucci","year":"2020","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.jconrel.2026.114847_bb0520","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12951-020-00599-1","article-title":"Surface chemistry governs the sub-organ transfer, clearance and toxicity of functional gold nanoparticles in the liver and kidney","volume":"18","author":"Li","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0525","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1038\/d41586-025-03480-z","article-title":"How nanobots are accelerating cancer-targeting therapies","volume":"646","author":"Heidt","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114847_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114419","article-title":"An oral H(2)S nanotherapeutics for hypertensive chronic kidney disease via synergistic antihypertensive and renoprotective activities","volume":"389","author":"Shao","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114847_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102898","article-title":"The landscape of nanomedical clinical trials","volume":"66","author":"Gultepe","year":"2026","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.114847_bb0540","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41581-025-01011-7","article-title":"RNA-based therapeutic opportunities for the treatment of kidney diseases","volume":"22","author":"Prins","year":"2026","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0545","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.7150\/thno.50905","article-title":"Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance","volume":"11","author":"Zhao","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.114847_bb0550","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.1007\/s12274-023-5547-8","article-title":"Renal tubule-targeted dexrazoxane suppresses ferroptosis in acute kidney injury by inhibiting ACMSD","volume":"16","author":"Zhang","year":"2023","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2026.114847_bb0555","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1007\/s11010-025-05297-w","article-title":"Targeting mitochondrial dysfunction: an innovative strategy for treating renal fibrosis","volume":"480","author":"Wu","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.jconrel.2026.114847_bb0560","article-title":"Fully Biocompatible Tantalum-Based Antioxidant Nanoshields for Proximal Tubule Epithelial Cells-Targeted Mitochondrial Holistic Protection in Acute Kidney Injury","volume":"38","author":"Yang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114847_bb0565","article-title":"Molecular mechanisms and physiological functions of autophagy in kidney diseases","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0570","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.7150\/thno.102559","article-title":"Trehalose activates autophagy to alleviate cisplatin-induced chronic kidney injury by targeting the mTOR-dependent TFEB signaling pathway","volume":"15","author":"Yang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.114847_bb0575","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.kint.2024.12.020","article-title":"Repurposing mitochondria-targeted therapeutics for kidney diseases","volume":"107","author":"Thompson","year":"2025","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2026.114847_bb0580","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.2174\/0929867327666201020151124","article-title":"The Mitochondrion-Targeted Antioxidants in Kidney Disease","volume":"28","author":"Li","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.114847_bb0585","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.114847_bb0590","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.114847_bb0595","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.kint.2023.03.007","article-title":"International Society of Nephrology first consensus guidance for preclinical animal studies in translational nephrology","volume":"104","author":"Nangaku","year":"2023","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2026.114847_bb0600","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94716","article-title":"Molecular characterization of the transition from acute to chronic kidney injury following ischemia\/reperfusion","volume":"2","author":"Liu","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jconrel.2026.114847_bb0605","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.kint.2024.07.034","article-title":"Targeted gene therapy for rare genetic kidney diseases","volume":"106","author":"Khare","year":"2024","journal-title":"Kidney Int."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592600249X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592600249X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:58:58Z","timestamp":1793944738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592600249X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":121,"alternative-id":["S016836592600249X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114847","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal-targeted drug delivery: overcoming barriers and charting the course","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114847"}}